The French R&D tax credit initiative, ‘Crédit d’Impôt Recherche’ (CIR), is a tax relief measure for companies focused on research and development. Companies based in France can benefit from a tax credit of 30% of the total amount of research and development expenditure when work is committed to Plextek.
Nigel Whittle, Head of Medical & Healthcare commented: “We are delighted to receive this accreditation, that both recognises Plextek as a provider of innovative research services and also allows our customers in France to benefit from up to 30% tax relief on their R&D expenditure”
This accreditation underlines Plextek’s commitment to research and innovation on a Global scale. We are proud to be able to serve our French customers better through achieving CIR.